nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP3A4—Imiquimod—skin cancer	0.159	0.233	CbGbCtD
Prochlorperazine—CYP3A4—Temozolomide—skin cancer	0.159	0.233	CbGbCtD
Prochlorperazine—CYP2D6—Vemurafenib—skin cancer	0.137	0.201	CbGbCtD
Prochlorperazine—CYP3A4—Vismodegib—skin cancer	0.11	0.162	CbGbCtD
Prochlorperazine—CYP3A4—Vemurafenib—skin cancer	0.087	0.128	CbGbCtD
Prochlorperazine—CYP3A4—Docetaxel—skin cancer	0.0299	0.0438	CbGbCtD
Prochlorperazine—Abnormal pigmentation—Temozolomide—skin cancer	0.0233	0.0731	CcSEcCtD
Prochlorperazine—Edema cerebral—Temozolomide—skin cancer	0.0142	0.0446	CcSEcCtD
Prochlorperazine—Amenorrhoea—Vismodegib—skin cancer	0.00791	0.0248	CcSEcCtD
Prochlorperazine—Brain oedema—Temozolomide—skin cancer	0.00768	0.0241	CcSEcCtD
Prochlorperazine—Pigmentation disorder—Temozolomide—skin cancer	0.00658	0.0206	CcSEcCtD
Prochlorperazine—Pregnancy—Imiquimod—skin cancer	0.00645	0.0203	CcSEcCtD
Prochlorperazine—Altered state of consciousness—Temozolomide—skin cancer	0.00475	0.0149	CcSEcCtD
Prochlorperazine—Parkinsonism—Fluorouracil—skin cancer	0.00445	0.014	CcSEcCtD
Prochlorperazine—Sudden death—Fluorouracil—skin cancer	0.00395	0.0124	CcSEcCtD
Prochlorperazine—Eruption—Dactinomycin—skin cancer	0.00395	0.0124	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Temozolomide—skin cancer	0.00361	0.0113	CcSEcCtD
Prochlorperazine—Photosensitivity—Vemurafenib—skin cancer	0.00355	0.0111	CcSEcCtD
Prochlorperazine—Eczema—Imiquimod—skin cancer	0.00296	0.00929	CcSEcCtD
Prochlorperazine—Muscle spasms—Vismodegib—skin cancer	0.00292	0.00917	CcSEcCtD
Prochlorperazine—Nasal congestion—Imiquimod—skin cancer	0.00292	0.00916	CcSEcCtD
Prochlorperazine—Extrapyramidal disorder—Temozolomide—skin cancer	0.00291	0.00915	CcSEcCtD
Prochlorperazine—Cholestasis—Temozolomide—skin cancer	0.00289	0.00908	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Imiquimod—skin cancer	0.00282	0.00885	CcSEcCtD
Prochlorperazine—Eosinophilia—Vemurafenib—skin cancer	0.00267	0.00838	CcSEcCtD
Prochlorperazine—Systemic lupus erythematosus—Docetaxel—skin cancer	0.00264	0.00828	CcSEcCtD
Prochlorperazine—Menstruation irregular—Docetaxel—skin cancer	0.00264	0.00828	CcSEcCtD
Prochlorperazine—Liver injury—Temozolomide—skin cancer	0.00261	0.00819	CcSEcCtD
Prochlorperazine—Urinary retention—Imiquimod—skin cancer	0.00253	0.00794	CcSEcCtD
Prochlorperazine—Amenorrhoea—Temozolomide—skin cancer	0.0025	0.00784	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Vemurafenib—skin cancer	0.00246	0.00772	CcSEcCtD
Prochlorperazine—Skin disorder—Vismodegib—skin cancer	0.00241	0.00757	CcSEcCtD
Prochlorperazine—Deep vein thrombosis—Docetaxel—skin cancer	0.0024	0.00753	CcSEcCtD
Prochlorperazine—Eruption—Docetaxel—skin cancer	0.00237	0.00745	CcSEcCtD
Prochlorperazine—Influenza—Imiquimod—skin cancer	0.0023	0.00722	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Dactinomycin—skin cancer	0.00228	0.00715	CcSEcCtD
Prochlorperazine—Gait disturbance—Temozolomide—skin cancer	0.00225	0.00706	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Temozolomide—skin cancer	0.0022	0.00689	CcSEcCtD
Prochlorperazine—Pancytopenia—Imiquimod—skin cancer	0.00218	0.00685	CcSEcCtD
Prochlorperazine—Oedema peripheral—Vemurafenib—skin cancer	0.00212	0.00667	CcSEcCtD
Prochlorperazine—Constipation—Vismodegib—skin cancer	0.00212	0.00666	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Imiquimod—skin cancer	0.00212	0.00665	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Imiquimod—skin cancer	0.0021	0.00659	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Temozolomide—skin cancer	0.00206	0.00647	CcSEcCtD
Prochlorperazine—Erythema multiforme—Vemurafenib—skin cancer	0.00204	0.0064	CcSEcCtD
Prochlorperazine—Throat sore—Docetaxel—skin cancer	0.00203	0.00636	CcSEcCtD
Prochlorperazine—Oropharyngeal discomfort—Docetaxel—skin cancer	0.00201	0.0063	CcSEcCtD
Prochlorperazine—Dermatitis contact—Fluorouracil—skin cancer	0.002	0.00628	CcSEcCtD
Prochlorperazine—Erythema—Vemurafenib—skin cancer	0.00188	0.0059	CcSEcCtD
Prochlorperazine—Coma—Fluorouracil—skin cancer	0.00185	0.0058	CcSEcCtD
Prochlorperazine—Pruritus—Vismodegib—skin cancer	0.00175	0.00551	CcSEcCtD
Prochlorperazine—Nasal congestion—Temozolomide—skin cancer	0.00175	0.00549	CcSEcCtD
Prochlorperazine—Erythema multiforme—Imiquimod—skin cancer	0.00174	0.00546	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Temozolomide—skin cancer	0.00169	0.0053	CcSEcCtD
Prochlorperazine—Photosensitivity—Fluorouracil—skin cancer	0.00167	0.00525	CcSEcCtD
Prochlorperazine—Amenorrhoea—Docetaxel—skin cancer	0.00166	0.00522	CcSEcCtD
Prochlorperazine—Arrhythmia—Imiquimod—skin cancer	0.00164	0.00516	CcSEcCtD
Prochlorperazine—Cough—Vemurafenib—skin cancer	0.00164	0.00514	CcSEcCtD
Prochlorperazine—Oropharyngeal pain—Docetaxel—skin cancer	0.00161	0.00504	CcSEcCtD
Prochlorperazine—Erythema—Imiquimod—skin cancer	0.0016	0.00503	CcSEcCtD
Prochlorperazine—Rash—Vismodegib—skin cancer	0.00156	0.00491	CcSEcCtD
Prochlorperazine—Dermatitis—Vismodegib—skin cancer	0.00156	0.00491	CcSEcCtD
Prochlorperazine—Pancytopenia—Bleomycin—skin cancer	0.00155	0.00487	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Vemurafenib—skin cancer	0.00153	0.00481	CcSEcCtD
Prochlorperazine—Dysphagia—Dactinomycin—skin cancer	0.00152	0.00478	CcSEcCtD
Prochlorperazine—Infection—Vemurafenib—skin cancer	0.00152	0.00478	CcSEcCtD
Prochlorperazine—Skin disorder—Vemurafenib—skin cancer	0.00149	0.00467	CcSEcCtD
Prochlorperazine—Agitation—Imiquimod—skin cancer	0.00147	0.00462	CcSEcCtD
Prochlorperazine—Angioedema—Imiquimod—skin cancer	0.00146	0.00459	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Docetaxel—skin cancer	0.00146	0.00458	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Docetaxel—skin cancer	0.00146	0.00458	CcSEcCtD
Prochlorperazine—Pancytopenia—Dactinomycin—skin cancer	0.00145	0.00454	CcSEcCtD
Prochlorperazine—Hypotension—Vemurafenib—skin cancer	0.00143	0.0045	CcSEcCtD
Prochlorperazine—Cough—Imiquimod—skin cancer	0.0014	0.00439	CcSEcCtD
Prochlorperazine—Cardiac arrest—Fluorouracil—skin cancer	0.0014	0.00438	CcSEcCtD
Prochlorperazine—Convulsion—Imiquimod—skin cancer	0.00139	0.00436	CcSEcCtD
Prochlorperazine—Dysphagia—Temozolomide—skin cancer	0.00138	0.00432	CcSEcCtD
Prochlorperazine—Dry mouth—Imiquimod—skin cancer	0.00133	0.00419	CcSEcCtD
Prochlorperazine—Constipation—Vemurafenib—skin cancer	0.00131	0.00411	CcSEcCtD
Prochlorperazine—Pancytopenia—Temozolomide—skin cancer	0.00131	0.00411	CcSEcCtD
Prochlorperazine—Oedema—Imiquimod—skin cancer	0.00131	0.0041	CcSEcCtD
Prochlorperazine—Infection—Imiquimod—skin cancer	0.0013	0.00408	CcSEcCtD
Prochlorperazine—Skin disorder—Imiquimod—skin cancer	0.00127	0.00399	CcSEcCtD
Prochlorperazine—Dysphagia—Fluorouracil—skin cancer	0.00127	0.00398	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Temozolomide—skin cancer	0.00127	0.00398	CcSEcCtD
Prochlorperazine—Agranulocytosis—Dactinomycin—skin cancer	0.00127	0.00398	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Temozolomide—skin cancer	0.00126	0.00395	CcSEcCtD
Prochlorperazine—Eosinophilia—Fluorouracil—skin cancer	0.00126	0.00394	CcSEcCtD
Prochlorperazine—Weight increased—Temozolomide—skin cancer	0.00125	0.00394	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Temozolomide—skin cancer	0.00124	0.0039	CcSEcCtD
Prochlorperazine—Body temperature increased—Vemurafenib—skin cancer	0.00121	0.0038	CcSEcCtD
Prochlorperazine—Pancytopenia—Fluorouracil—skin cancer	0.0012	0.00378	CcSEcCtD
Prochlorperazine—Insomnia—Imiquimod—skin cancer	0.00118	0.00371	CcSEcCtD
Prochlorperazine—Dyspnoea—Imiquimod—skin cancer	0.00117	0.00366	CcSEcCtD
Prochlorperazine—Somnolence—Imiquimod—skin cancer	0.00116	0.00365	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Fluorouracil—skin cancer	0.00116	0.00364	CcSEcCtD
Prochlorperazine—Erythema multiforme—Dactinomycin—skin cancer	0.00115	0.00362	CcSEcCtD
Prochlorperazine—Erythema—Bleomycin—skin cancer	0.00114	0.00357	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vemurafenib—skin cancer	0.00113	0.00355	CcSEcCtD
Prochlorperazine—Oedema peripheral—Temozolomide—skin cancer	0.00109	0.00341	CcSEcCtD
Prochlorperazine—Pruritus—Vemurafenib—skin cancer	0.00108	0.0034	CcSEcCtD
Prochlorperazine—Erythema—Dactinomycin—skin cancer	0.00106	0.00333	CcSEcCtD
Prochlorperazine—Agranulocytosis—Fluorouracil—skin cancer	0.00106	0.00332	CcSEcCtD
Prochlorperazine—Erythema multiforme—Temozolomide—skin cancer	0.00104	0.00327	CcSEcCtD
Prochlorperazine—Urticaria—Imiquimod—skin cancer	0.00104	0.00326	CcSEcCtD
Prochlorperazine—Body temperature increased—Imiquimod—skin cancer	0.00103	0.00324	CcSEcCtD
Prochlorperazine—Leukopenia—Bleomycin—skin cancer	0.00102	0.0032	CcSEcCtD
Prochlorperazine—Dizziness—Vemurafenib—skin cancer	0.00101	0.00318	CcSEcCtD
Prochlorperazine—Cough—Bleomycin—skin cancer	0.000993	0.00312	CcSEcCtD
Prochlorperazine—Rash—Vemurafenib—skin cancer	0.000966	0.00303	CcSEcCtD
Prochlorperazine—Dermatitis—Vemurafenib—skin cancer	0.000965	0.00303	CcSEcCtD
Prochlorperazine—Hypersensitivity—Imiquimod—skin cancer	0.000963	0.00302	CcSEcCtD
Prochlorperazine—Headache—Vemurafenib—skin cancer	0.00096	0.00301	CcSEcCtD
Prochlorperazine—Erythema—Temozolomide—skin cancer	0.00096	0.00301	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—skin cancer	0.00095	0.00298	CcSEcCtD
Prochlorperazine—Oedema—Bleomycin—skin cancer	0.000928	0.00292	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Bleomycin—skin cancer	0.000928	0.00292	CcSEcCtD
Prochlorperazine—Pruritus—Imiquimod—skin cancer	0.000925	0.0029	CcSEcCtD
Prochlorperazine—Infection—Bleomycin—skin cancer	0.000922	0.0029	CcSEcCtD
Prochlorperazine—Dysphagia—Docetaxel—skin cancer	0.000916	0.00288	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Bleomycin—skin cancer	0.000909	0.00285	CcSEcCtD
Prochlorperazine—Arrhythmia—Fluorouracil—skin cancer	0.000907	0.00285	CcSEcCtD
Prochlorperazine—Vision blurred—Temozolomide—skin cancer	0.000904	0.00284	CcSEcCtD
Prochlorperazine—Tremor—Temozolomide—skin cancer	0.000899	0.00282	CcSEcCtD
Prochlorperazine—Erythema—Fluorouracil—skin cancer	0.000884	0.00278	CcSEcCtD
Prochlorperazine—Agitation—Temozolomide—skin cancer	0.000882	0.00277	CcSEcCtD
Prochlorperazine—Angioedema—Temozolomide—skin cancer	0.000877	0.00275	CcSEcCtD
Prochlorperazine—Pancytopenia—Docetaxel—skin cancer	0.00087	0.00273	CcSEcCtD
Prochlorperazine—Hypotension—Bleomycin—skin cancer	0.000868	0.00272	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—skin cancer	0.000866	0.00272	CcSEcCtD
Prochlorperazine—Dizziness—Imiquimod—skin cancer	0.000864	0.00271	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—skin cancer	0.00086	0.0027	CcSEcCtD
Prochlorperazine—Leukopenia—Temozolomide—skin cancer	0.000859	0.0027	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—skin cancer	0.000848	0.00266	CcSEcCtD
Prochlorperazine—Cough—Temozolomide—skin cancer	0.000837	0.00263	CcSEcCtD
Prochlorperazine—Weight increased—Docetaxel—skin cancer	0.000833	0.00262	CcSEcCtD
Prochlorperazine—Vision blurred—Fluorouracil—skin cancer	0.000833	0.00262	CcSEcCtD
Prochlorperazine—Convulsion—Temozolomide—skin cancer	0.000831	0.00261	CcSEcCtD
Prochlorperazine—Dyspnoea—Bleomycin—skin cancer	0.000828	0.0026	CcSEcCtD
Prochlorperazine—Rash—Imiquimod—skin cancer	0.000824	0.00259	CcSEcCtD
Prochlorperazine—Dermatitis—Imiquimod—skin cancer	0.000823	0.00258	CcSEcCtD
Prochlorperazine—Headache—Imiquimod—skin cancer	0.000819	0.00257	CcSEcCtD
Prochlorperazine—Dry mouth—Temozolomide—skin cancer	0.000799	0.00251	CcSEcCtD
Prochlorperazine—Jaundice—Docetaxel—skin cancer	0.000796	0.0025	CcSEcCtD
Prochlorperazine—Leukopenia—Fluorouracil—skin cancer	0.000791	0.00249	CcSEcCtD
Prochlorperazine—Oedema—Temozolomide—skin cancer	0.000783	0.00246	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Temozolomide—skin cancer	0.000783	0.00246	CcSEcCtD
Prochlorperazine—Infection—Temozolomide—skin cancer	0.000778	0.00244	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Temozolomide—skin cancer	0.000767	0.00241	CcSEcCtD
Prochlorperazine—Convulsion—Fluorouracil—skin cancer	0.000766	0.00241	CcSEcCtD
Prochlorperazine—Agranulocytosis—Docetaxel—skin cancer	0.000762	0.00239	CcSEcCtD
Prochlorperazine—Skin disorder—Temozolomide—skin cancer	0.000761	0.00239	CcSEcCtD
Prochlorperazine—Urticaria—Bleomycin—skin cancer	0.000738	0.00232	CcSEcCtD
Prochlorperazine—Body temperature increased—Bleomycin—skin cancer	0.000734	0.0023	CcSEcCtD
Prochlorperazine—Oedema peripheral—Docetaxel—skin cancer	0.000722	0.00227	CcSEcCtD
Prochlorperazine—Oedema—Fluorouracil—skin cancer	0.000722	0.00227	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Fluorouracil—skin cancer	0.000722	0.00227	CcSEcCtD
Prochlorperazine—Infection—Fluorouracil—skin cancer	0.000717	0.00225	CcSEcCtD
Prochlorperazine—Insomnia—Temozolomide—skin cancer	0.000708	0.00222	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Fluorouracil—skin cancer	0.000706	0.00222	CcSEcCtD
Prochlorperazine—Dyspnoea—Temozolomide—skin cancer	0.000698	0.00219	CcSEcCtD
Prochlorperazine—Somnolence—Temozolomide—skin cancer	0.000696	0.00219	CcSEcCtD
Prochlorperazine—Erythema multiforme—Docetaxel—skin cancer	0.000693	0.00218	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—skin cancer	0.000684	0.00215	CcSEcCtD
Prochlorperazine—Hypersensitivity—Bleomycin—skin cancer	0.000684	0.00215	CcSEcCtD
Prochlorperazine—Hypotension—Fluorouracil—skin cancer	0.000674	0.00212	CcSEcCtD
Prochlorperazine—Constipation—Temozolomide—skin cancer	0.00067	0.0021	CcSEcCtD
Prochlorperazine—Pruritus—Bleomycin—skin cancer	0.000657	0.00206	CcSEcCtD
Prochlorperazine—Arrhythmia—Docetaxel—skin cancer	0.000655	0.00206	CcSEcCtD
Prochlorperazine—Insomnia—Fluorouracil—skin cancer	0.000653	0.00205	CcSEcCtD
Prochlorperazine—Dyspnoea—Fluorouracil—skin cancer	0.000643	0.00202	CcSEcCtD
Prochlorperazine—Somnolence—Fluorouracil—skin cancer	0.000641	0.00201	CcSEcCtD
Prochlorperazine—Erythema—Docetaxel—skin cancer	0.000638	0.002	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—skin cancer	0.000638	0.002	CcSEcCtD
Prochlorperazine—Urticaria—Temozolomide—skin cancer	0.000622	0.00195	CcSEcCtD
Prochlorperazine—Body temperature increased—Temozolomide—skin cancer	0.000619	0.00194	CcSEcCtD
Prochlorperazine—Muscle spasms—Docetaxel—skin cancer	0.000614	0.00193	CcSEcCtD
Prochlorperazine—Rash—Bleomycin—skin cancer	0.000585	0.00184	CcSEcCtD
Prochlorperazine—Dermatitis—Bleomycin—skin cancer	0.000585	0.00184	CcSEcCtD
Prochlorperazine—Hypersensitivity—Temozolomide—skin cancer	0.000577	0.00181	CcSEcCtD
Prochlorperazine—Urticaria—Fluorouracil—skin cancer	0.000573	0.0018	CcSEcCtD
Prochlorperazine—Leukopenia—Docetaxel—skin cancer	0.000571	0.00179	CcSEcCtD
Prochlorperazine—Body temperature increased—Fluorouracil—skin cancer	0.00057	0.00179	CcSEcCtD
Prochlorperazine—Cough—Docetaxel—skin cancer	0.000557	0.00175	CcSEcCtD
Prochlorperazine—Pruritus—Temozolomide—skin cancer	0.000554	0.00174	CcSEcCtD
Prochlorperazine—Convulsion—Docetaxel—skin cancer	0.000553	0.00174	CcSEcCtD
Prochlorperazine—Rash—Dactinomycin—skin cancer	0.000546	0.00171	CcSEcCtD
Prochlorperazine—Hypersensitivity—Fluorouracil—skin cancer	0.000532	0.00167	CcSEcCtD
Prochlorperazine—Dry mouth—Docetaxel—skin cancer	0.000531	0.00167	CcSEcCtD
Prochlorperazine—Oedema—Docetaxel—skin cancer	0.000521	0.00164	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Docetaxel—skin cancer	0.000521	0.00164	CcSEcCtD
Prochlorperazine—Dizziness—Temozolomide—skin cancer	0.000518	0.00163	CcSEcCtD
Prochlorperazine—Infection—Docetaxel—skin cancer	0.000517	0.00162	CcSEcCtD
Prochlorperazine—Pruritus—Fluorouracil—skin cancer	0.00051	0.0016	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Docetaxel—skin cancer	0.00051	0.0016	CcSEcCtD
Prochlorperazine—Skin disorder—Docetaxel—skin cancer	0.000506	0.00159	CcSEcCtD
Prochlorperazine—Rash—Temozolomide—skin cancer	0.000494	0.00155	CcSEcCtD
Prochlorperazine—Dermatitis—Temozolomide—skin cancer	0.000493	0.00155	CcSEcCtD
Prochlorperazine—Headache—Temozolomide—skin cancer	0.000491	0.00154	CcSEcCtD
Prochlorperazine—Hypotension—Docetaxel—skin cancer	0.000487	0.00153	CcSEcCtD
Prochlorperazine—Dizziness—Fluorouracil—skin cancer	0.000477	0.0015	CcSEcCtD
Prochlorperazine—Insomnia—Docetaxel—skin cancer	0.000471	0.00148	CcSEcCtD
Prochlorperazine—Dyspnoea—Docetaxel—skin cancer	0.000464	0.00146	CcSEcCtD
Prochlorperazine—Somnolence—Docetaxel—skin cancer	0.000463	0.00145	CcSEcCtD
Prochlorperazine—Rash—Fluorouracil—skin cancer	0.000455	0.00143	CcSEcCtD
Prochlorperazine—Dermatitis—Fluorouracil—skin cancer	0.000455	0.00143	CcSEcCtD
Prochlorperazine—Headache—Fluorouracil—skin cancer	0.000452	0.00142	CcSEcCtD
Prochlorperazine—Constipation—Docetaxel—skin cancer	0.000445	0.0014	CcSEcCtD
Prochlorperazine—Body temperature increased—Docetaxel—skin cancer	0.000412	0.00129	CcSEcCtD
Prochlorperazine—Hypersensitivity—Docetaxel—skin cancer	0.000384	0.0012	CcSEcCtD
Prochlorperazine—Pruritus—Docetaxel—skin cancer	0.000368	0.00116	CcSEcCtD
Prochlorperazine—Dizziness—Docetaxel—skin cancer	0.000344	0.00108	CcSEcCtD
Prochlorperazine—Rash—Docetaxel—skin cancer	0.000328	0.00103	CcSEcCtD
Prochlorperazine—Dermatitis—Docetaxel—skin cancer	0.000328	0.00103	CcSEcCtD
Prochlorperazine—Headache—Docetaxel—skin cancer	0.000326	0.00102	CcSEcCtD
